Rapid improvement of hypoxemia by the use of rituximab in patients with pulmonary intravascular lymphoma.
Matsue
Kosei
K
Takeuchi
Masami
M
Uryu
Hidetaka
H
Koseki
Mihoko
M
Asada
Noboru
N
Kaneko
Yosinori
Y
D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006801:Humans; D000860:Hypoxia / Q000188:drug therapy*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008875:Middle Aged; D011651:Pulmonary Artery / Q000473:pathology; D000069283:Rituximab; D019043:Vascular Neoplasms / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab